NCT05679765

Efficacy of GONB in Patients of Migraine

Analgesic Efficacy of Ultrasound-guided Greater Occipital Nerve Block in Patients of Chronic Migraine

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 50 (actual)
• Sponsor: Pain Medicine Department · Academic / Other
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

The study was carried to determine the analgesic efficacy of greater occipital nerve block in patients of migraine. It was a randomised controlled which took place from april 2022 - october 2022. Fifty patients suffering from migraine were included in the study. Patients in Group G were given greater occipital nerve block (GONB) with lignocaine and dexamethasone under ultrasound guidance while those in Group S were given saline 0.9% as placebo. Pain score using Numeric Rating Scale and number of headache days was assessed at four,eight and twelve weeks after the procedure as a primary outcome. Total headache days were recorded as a secondary outcome.

Conditions

• Chronic Migraine
• Headache

Interventions

Type	Name	Description
DRUG	Greater Occipital Nerve Block with dexamethasone and lidocaine	Ultrasound guided Greater occipital nerve block on the side of headache
DRUG	Greater Occipital Nerve Block with 0.9% saline	Ultrasound guided Greater occipital nerve block on the side of headache

Timeline

• Start date: 2022-04-01
• Primary completion: 2022-08-31
• Completion: 2022-08-31
• First posted: 2023-01-11
• Last updated: 2023-01-12

Locations

1 site across 1 country: Pakistan